A Retrospective Study to Characterize Participants With Propionic Acidemia
A Retrospective Cohort Study to Characterize Propionic Acidemia Patients
Sponsor: ModernaTX, Inc.
This observational or N/A phase trial investigates Propionic Acidemia and is currently actively recruiting participants. ModernaTX, Inc. leads this study, which shows 12 recorded versions since 2023 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Feb 2026 — Present [monthly]
Recruiting
Status: Active Not Recruiting → Recruiting
-
Oct 2025 — Feb 2026 [monthly]
Active Not Recruiting
-
Sep 2025 — Oct 2025 [monthly]
Active Not Recruiting
-
Oct 2024 — Sep 2025 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Recruiting
▶ Show 7 earlier versions
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Mar 2024 — Jul 2024 [monthly]
Recruiting
-
Sep 2023 — Mar 2024 [monthly]
Recruiting
-
Aug 2023 — Sep 2023 [monthly]
Recruiting
-
Jun 2023 — Aug 2023 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
May 2023 — Jun 2023 [monthly]
Not Yet Recruiting
-
Apr 2023 — May 2023 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- ModernaTX, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .